omeprazole has been researched along with Encephalopathy, Hepatic in 9 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "pylori infection is associated with hepatic encephalopathy, especially in younger patients with decompensated liver disease." | 1.30 | Analysis of risk factors for chronic hepatic encephalopathy: the role of Helicobacter pylori infection. ( Dasani, BM; Lieber, CS; Sigal, SH, 1998) |
| "Omeprazole is a new hydrogen-potassium adenosine triphosphatase antagonist with indications for severe reflux esophagitis and Zollinger-Ellison syndrome." | 1.28 | Fulminant hepatic failure related to omeprazole. ( Brogan, M; Cook-Glenn, C; Greenson, J; Jochem, V; Kirkpatrick, R; Sturgis, T, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsai, CF | 1 |
| Chen, MH | 1 |
| Wang, YP | 1 |
| Chu, CJ | 1 |
| Huang, YH | 1 |
| Lin, HC | 1 |
| Hou, MC | 1 |
| Lee, FY | 1 |
| Su, TP | 1 |
| Lu, CL | 1 |
| Owens, SL | 1 |
| Parnell, NK | 1 |
| Zullo, A | 1 |
| Hassan, C | 1 |
| Morini, S | 1 |
| Chen, SJ | 1 |
| Wang, LJ | 1 |
| Zhu, Q | 1 |
| Cai, JT | 1 |
| Chen, T | 1 |
| Si, JM | 1 |
| del Río Fernández, M | 1 |
| Plagaro Cordero, ME | 1 |
| de Frutos Arribas, JF | 1 |
| Bellido Casado, J | 1 |
| Velicia Llanes, R | 1 |
| Dasani, BM | 1 |
| Sigal, SH | 1 |
| Lieber, CS | 1 |
| Vásconez, C | 1 |
| Elizalde, JI | 1 |
| Llach, J | 1 |
| Ginès, A | 1 |
| de la Rosa, C | 1 |
| Fernández, RM | 1 |
| Mas, A | 1 |
| Santamaría, J | 1 |
| Bordas, JM | 1 |
| Piqué, JM | 1 |
| Terés, J | 1 |
| Mertens, PR | 1 |
| Schönfelder, T | 1 |
| Handt, S | 1 |
| Kierdorf, H | 1 |
| Marschall, H | 1 |
| Busch, N | 1 |
| Heintz, B | 1 |
| Sieberth, H | 1 |
| Jochem, V | 1 |
| Kirkpatrick, R | 1 |
| Greenson, J | 1 |
| Brogan, M | 1 |
| Sturgis, T | 1 |
| Cook-Glenn, C | 1 |
1 review available for omeprazole and Encephalopathy, Hepatic
| Article | Year |
|---|---|
Helicobacter pylori infection in patients with liver cirrhosis: facts and fictions.
Topics: Ammonia; Anti-Ulcer Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; | 2003 |
8 other studies available for omeprazole and Encephalopathy, Hepatic
| Article | Year |
|---|---|
Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administrative Claims, Healthcare; Adult; Aged; Case-Contro | 2017 |
What is the evidence? Portosystemic shunt in a dog.
Topics: Animals; Anti-Ulcer Agents; Diet; Dog Diseases; Dogs; Evidence-Based Medicine; Gastrointestinal Hemo | 2011 |
Effect of H pylori infection and its eradication on hyperammo-nemia and hepatic encephalopathy in cirrhotic patients.
Topics: Adult; Aged; Alkylating Agents; Anti-Bacterial Agents; Anti-Ulcer Agents; China; Clarithromycin; Fem | 2008 |
[Hepatic encephalopathy related to omeprazole].
Topics: Anti-Ulcer Agents; Hepatic Encephalopathy; Humans; Male; Middle Aged; Omeprazole; Time Factors | 1997 |
Analysis of risk factors for chronic hepatic encephalopathy: the role of Helicobacter pylori infection.
Topics: Ammonia; Amoxicillin; Anti-Ulcer Agents; Ascites; Chronic Disease; Diuretics; Helicobacter Infection | 1998 |
Helicobacter pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication.
Topics: Aged; Ammonia; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; | 1999 |
Long-term extracorporeal bilirubin elimination: A case report on cascade resin plasmaperfusion.
Topics: Acute Kidney Injury; Bile Acids and Salts; Charcoal; Chemical and Drug Induced Liver Injury; Cholest | 1998 |
Fulminant hepatic failure related to omeprazole.
Topics: Esophagitis, Peptic; Hepatic Encephalopathy; Humans; Male; Middle Aged; Omeprazole | 1992 |